Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

AI Breakthrough Announced in Melanoma Detection

Proscia
By Author Proscia | October 7, 2021

Proscia, a provider of digital and computational pathology solutions, has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with a high degree of accuracy. The findings illustrate the promise of AI to deliver faster diagnoses, improve patient outcomes, and optimize laboratory economics in the routine practice of pathology.

Our website uses cookies. By using this site, you agree to its use of cookies.